Related Experiment Videos
A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy
R M Aigner1, G F Fueger, S Lax
1Department of Radiology, Karl-Franzens-University of Graz, Austria.
Nuklearmedizin. Nuclear Medicine
|December 12, 1997
Abstract:
Recent studies indicate that Tc-99m-Sestamibi (MIBI, DuPont Pharma) is a useful tracer for detecting parathyroid adenomas. We present a patient with focal Tc-99m-MIBI uptake in parathyroid carcinoma which has only been described once before (1). Tc-99m-MIBI scintigraphy may be considered for diagnosing pathological parathyroid tissue. But presently the histopathological examination only allows the differentiation between adenoma and carcinoma.